发明名称 2,4,5-TRISUBSTITUTED THIAZOLYL DERIVATIVES ANT THEIR ANTIINFLAMMATORY ACTIVITY
摘要 This invention concerns the use of a compound of formula (I) a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine and a stereochemically isomeric form thereof, wherein Z is halo; C<SUB>1-6</SUB>alkyl; C<SUB>1-6</SUB>alkyl substituted with hydroxy, carboxyl, cyano, amino, mono- or di(C<SUB>1-6</SUB>alkyl)amino, aminocarbonyl, mono- or di(C<SUB>1-6</SUB>alkyl)aminocarbonyl, C<SUB>1-6</SUB>alkyloxycarbonyl or C<SUB>1-6</SUB>alkyloxy; polyhaloC<SUB>1-4</SUB>alkyl; C<SUB>1-4</SUB>alkyloxy; cyano; amino; aminocarbonyl; mono- or di(C<SUB>1-6</SUB>alkyl)aminocarbonyl; C<SUB>1-6</SUB>alkyloxycarbonyl; C<SUB>1-6</SUB>alkylcarbonyloxy; H<SUB>2</SUB>N-S(-O)<SUB>2</SUB>-; mono- or di(C<SUB>1-6</SUB>alkyl)amino-S(-O)<SUB>2</SUB>; -C(-N-R<SUP>x</SUP>)NR<SUP>y</SUP>R<SUP>z</SUP>; Q is an optionally substituted carbocycle or an optionally substituted heterocycle; L is substituted phenyl or an optionally substituted monocyclic 5 or 6-membered partially saturated or aromatic heterocycle or a bicyclic partially saturated or aromatic heterocycle; aryl is optionally substituted phenyl; for the manufacture of a medicament for the prevention or the treatment of diseases mediated through TNF-alpha and/or IL-12.
申请公布号 PL210475(B1) 申请公布日期 2012.01.31
申请号 PL20020368241 申请日期 2002.08.09
申请人 JANSSEN PHARMACEUTICA N.V. 发明人 LOVE CHRISTOPHER JOHN;VAN WAUWE JEAN PIERRE FRANS;DE BRABANDER MARC J.;MOSES ROGER CLIVE;GONCHARENKO MYKHAYLO;COOYMANS LUDWIG PAUL;VANDERMAESEN NELE;DIELS GASTON STANISLAS MARCELLA;SIBLEY ANTHONY WILLIAM;NOULA CATERINA
分类号 A61K31/426;A61K31/427;A61K31/497;A61K31/506;A61K31/53;A61K31/5377;A61P1/00;A61P1/04;A61P1/16;A61P5/00;A61P9/00;A61P9/04;A61P9/10;A61P11/00;A61P17/00;A61P17/02;A61P17/06;A61P19/02;A61P19/10;A61P25/16;A61P27/02;A61P27/16;A61P29/00;A61P31/04;A61P31/12;A61P31/22;A61P33/14;A61P35/00;A61P37/02;A61P37/06;A61P37/08;A61P39/02;C07D277/24;C07D277/28;C07D417/04;C07D417/14 主分类号 A61K31/426
代理机构 代理人
主权项
地址